Fig. 2From: Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolizationComparison of overall survival and disease-free survival between the PA-TACE and non-TACE groups in HCC patients with γ-GT ≤ 54 U/L. (A, B), Overall survival and disease-free survival before PSM. (C, D), Overall survival and disease-free survival after PSMBack to article page